Metadata
- Name
- Use Lay Language. CAA-ri : a Series of 28 Patients
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT03187886
- Description
- INTRODUCTION: Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a very rare
manifestation of cerebral amyloid angiopathy, characterized by acute/subacute neurological
deterioration and T2/FLAIR corticosubcortical or deep white matter hyperintensity. With the
advent of new diagnostic criteria, there are more and more case reports and series reported;
nevertheless, MRI findings and follow-up data need to be thoroughly described.
OBJECTIVES: Our aim in this multicentrical and retrospective study was to describe the
clinical and radiological features of patients with CAA-ri and assess long-term prognosis.
METHODS: We reviewed the characteristics of 28 patients with CAA-ri including clinical data,
systematic MRI analysis, cerebrospinal fluid results (including Alzheimer's disease
biomarkers) and APOE genotype.
HYPOTHESIS: We aimed at describing the clinical and radiological characteristics of a cohort
of patients with CAA-ri. - Data or Study Types
- clinical trial
- Keywords
- CAA-RI, MRI, Intracerebral hemorrhage, Cerebral amyloid angiopathy
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2017
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT03187886
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT03187886